Allison Smith, MD
Ophthalmology · Nashville, TNNPI 1528030871
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $11,460 of the $12,908 with a category attached, or 88.8%. 29 manufacturers reported payments, led by AbbVie at 24.3% of the total. Among ophthalmology clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 420 payments — averaging $30.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Johnson & Johnson Surgical Vision, Inc.$3K
- Alcon$1K
- Harrow Eye, LLC$1K
- Novartis$670
- Tarsus Pharmaceuticals, Inc.$664
- plus $3K from 23 others
What the payments were for
- Travel & lodging$1,1109%
- Food & beverage$11,46089%
- Education$3383%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 149 | $3,139 |
| Johnson & Johnson Surgical Vision, Inc. | 33 | $2,748 |
| Alcon | 37 | $1,323 |
| Harrow Eye, LLC | 21 | $1,217 |
| Novartis | 36 | $670 |
| Tarsus Pharmaceuticals, Inc. | 17 | $664 |
| Sun Pharmaceutical Industries Inc. | 29 | $531 |
| Bausch & Lomb Americas Inc. | 23 | $414 |
| Oyster Point Pharma, Inc. | 15 | $394 |
| Rxsight Inc | 6 | $268 |
| Sight Sciences, Inc. | 4 | $230 |
| Kala Pharmaceuticals, Inc. | 9 | $168 |
| Dompe US, Inc. | 1 | $125 |
| Genentech USA, Inc. | 1 | $122 |
| Thea Pharma Inc. | 6 | $120 |
| Aerie Pharmaceuticals, Inc. | 6 | $120 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 6 | $115 |
| NEW World Medical,inc. | 2 | $111 |
| Glaukos Corporation | 3 | $93 |
| Shire North American Group Inc | 5 | $89 |
| Ivantis, Inc | 1 | $64 |
| Dermira, Inc. | 2 | $42 |
| Ocular Therapeutix, Inc. | 2 | $27 |
| Mallinckrodt Enterprises LLC | 1 | $25 |
| Novo Nordisk | 1 | $20 |
| Alcon Research LLC | 1 | $20 |
| Biotissue Holdings Inc. | 1 | $18 |
| Boston Scientific | 1 | $18 |
| Eyevance Pharmaceuticals LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tecnis 1-piece IOL$1,404
- Tecnis 3-piece IOL$1,404
- Tecnis Symphony IOL$1,404
- Tecnis Symphony Toric IOL$1,404
- VEVYE$408
- ARGOS$378
- DURYSTA$367
- XDEMVY$230
- Tecnis IOL$192
- Whitestar Signature$192
- RXSIGHT CONTACT LENS$148
- RXSIGHT INJECTOR CARTRIDGE$148
- RXSIGHT INJECTOR HANDPIECE$148
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$148
- LIGHT ADJUSTABLE LENS (LAL)$148
- Clareon$146
- OMNI(R) SURGICAL SYSTEM (US)$135
- Oxervate$125
- VABYSMO$122
- LUMIGAN$119
How this compares
$12,908 in reported general payments places this provider in the 90th percentile of 323 ophthalmology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 168 | $165,868 |
| XiidraLifitegrast | 103 | $128,225 |
| Cyclosporine | 103 | $59,644 |
| LumiganBimatoprost | 115 | $41,263 |
| CombiganBrimonidine Tartrate/Timolol | 108 | $36,159 |
| VyzultaLatanoprostene Bunod | 40 | $19,943 |
| MieboPerfluorohexyloctane/Pf | 26 | $18,994 |
| TyrvayaVarenicline Tartrate | 12 | $13,716 |
| Latanoprost | 927 | $13,615 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 531 | $13,495 |
| Bromfenac Sodium | 113 | $13,481 |
| RhopressaNetarsudil Mesylate | 31 | $12,626 |
| Prednisolone Acetate | 223 | $11,662 |
| CequaCyclosporine | 17 | $10,676 |
| RocklatanNetarsudil Mesylat/Latanoprost | 26 | $10,016 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Lumigan, Combigan, Alphagan P | $3,139 | $249,172403 claims |
| Bausch & Lomb Americas Inc.Xiidra, Vyzulta, Miebo | $414 | $167,162169 claims |
| Aerie Pharmaceuticals, Inc.Rhopressa, Rocklatan | $120 | $22,64257 claims |
| Oyster Point Pharma, Inc.Tyrvaya | $394 | $13,71612 claims |
| Sun Pharmaceutical Industries Inc.Cequa | $531 | $10,67617 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCProlensa, Loteprednol Etabonate | $115 | $7,62232 claims |
| NovartisIlevro | $670 | $6,33017 claims |
| AlconSimbrinza | $1,323 | $4,06619 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 323 ophthalmology providers in Tennessee.
Other ophthalmology in Nashville
- Deborah ShermanNashville$3M
- Brian BiesmanNashville$630K
- Edward ChaumNashville$158K
- Jeffrey HornNashville$106K
- Avni FinnNashville$57K
- Louise MawnNashville$56K
- Jeffrey KammerNashville$30K
- Gary JerkinsNashville$15K
- Christine ShiehNashville$10K
- Ira ShivitzNashville$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.